Journals / Namık Kemal Tıp Dergisi / 2022 / Cilt: 10 - Sayı: 2

Effects of Quercetin on Cisplatin-Induced Renal Damage in Wistar Albino Rats

Wistar Albino Sıçanlarda Sisplatin ile Oluşan Böbrek Hasarında Kuersetinin Etkileri

Pages
219–224
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In this study, we think that quercetin is histopathologically beneficial in the treatment of cisplatin-induced kidney damage.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:ABSTRACT Aim: Cisplatin is one of the effective antineoplastic drugs widely used in the treatment of many types of cancer.
📊
Key Findings & Data:Materials and Methods: Twenty-eight male Wistar albino rats were randomly selected and divided into 4 groups: Group 1: Control (no application), Group 2: Quercetin (25 mg/kg/7 days/intraperitoneal), Group 3: Cisplatin (7 mg/kg/single dose/ intraperitoneal), Group 4: Cisplatin+quercetin (7 mg) /kg/single dose/ intraperitoneal cisplatin followed by 25 mg/kg/7 days/ intraperitoneal quercetin).
💡
Conclusion & Impact:Conclusion: In this study, we think that quercetin is histopathologically beneficial in the treatment of cisplatin-induced kidney damage.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

ABSTRACT Aim: Cisplatin is one of the effective antineoplastic drugs widely used in the treatment of many types of cancer. Cisplatin has harmful effects such as nephrotoxicity, ototoxicity and cardiomyopathy. Quercetin is an antioxidant of the flavonoid group. In this study, it was aimed to investigate the therapeutic effects of quercetin against cisplatin-induced kidney damage in rats. Materials and Methods: Twenty-eight male Wistar albino rats were randomly selected and divided into 4 groups: Group 1: Control (no application), Group 2: Quercetin (25 mg/kg/7 days/intraperitoneal), Group 3: Cisplatin (7 mg/kg/single dose/ intraperitoneal), Group 4: Cisplatin+quercetin (7 mg) /kg/single dose/ intraperitoneal cisplatin followed by 25 mg/kg/7 days/ intraperitoneal quercetin). After routine histological follow-up, hematoxylin eosin and periodic acid-schiff staining were performed. Histopathological damage score was calculated. Caspase-3 immunostaining was performed and scored. Results: Control and quercetin groups had normal histological appearance. In the cisplatin group, dilatation of the tubules, epithelial shedding, vacuolization of the tubular epithelial cells, and loss of microvilli in the proximal tubules were detected. In addition, infiltration areas were also found in places. In addition, an increase in caspase-3 immunostaining intensity was detected in this group (p=0.000). Histopathological findings were significantly reduced in the cisplatin+quercetin group compared to the cisplatin group (p=0.001). Conclusion: In this study, we think that quercetin is histopathologically beneficial in the treatment of cisplatin-induced kidney damage.

Özet

ÖZ Amaç: Sisplatin birçok kanser türünün tedavisinde yaygın olarak kullanılan etkili antineoplastik ilaçlardan biridir. Sisplatinin nefrotoksisite, ototoksisite ve kardiyomiyopati gibi zararlı etkileri vardır. Kuersetin flavonoid grubu bir antioksidandır. Bu çalışmada, sıçanlarda sisplatin ile oluşturulan böbrek hasarına karşı kuersetinin tedavi edici etkilerinin incelenmesi amaçlanmıştır. Gereç ve Yöntem: Wistar albino cinsi 28 adet erkek sıçan rastgele seçilerek 4 gruba ayrıldı. Grup 1: Kontrol (uygulama yapılmadı), Grup 2: Kuersetin (25 mg/kg/7 gün/intraperitoneal), Grup 3: Sisplatin (7 mg/kg/tek doz/ intraperitoneal), Grup 4: Sisplatin+kuersetin (7 mg/kg/tek doz/ intraperitoneal sisplatin ardından 25 mg/kg/7 gün/ intraperitoneal kuersetin). Rutin histolojik takipten sonra hematoksilen-eozin ve periodic acid-schiff boyamaları yapıldı. Histopatolojik hasar skoru hesaplandı. Caspase-3 immün boyaması yapılarak skorlandı. Bulgular: Kontrol ve kuersetin grupları normal histolojik görünümdeydi. Sisplatin grubunda tubuler dilatasyon, tubul epitelinde dökülme, tubul epitel hücrelerinde vakuolizasyon ve proksimal tubullerde mikrovillus kaybı tespit edildi. Ayrıca yer yer infiltrasyon alanlarına da rastlandı. Sisplatin grubunun caspase-3 immün boyanma yoğunluğunda kontrol grubuna göre anlamlı artış tespit edildi (p=0,000). Sisplatin+kuersetin grubunda histopatolojik bulgular sisplatin grubuna kıyasla anlamlı derecede azalmıştı (p=0,001). Sonuç: Bu çalışmada, sisplatinin sebep olduğu böbrek hasarının tedavisinde kuersetinin histopatolojik açıdan yararlı olduğu düşüncesindeyiz.

🔖

Cite This Article

ÇETİNAVCI, D., ELBE, H., TAŞLIDERE, E., BOSTANCIERİ, N., TAŞLIDERE, A. (2022). Effects of Quercetin on Cisplatin-Induced Renal Damage in Wistar Albino Rats. Namık Kemal Tıp Dergisi, Cilt: 10 - Sayı: 2, 219–224. https://ajindex.com/articles/584006

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Ghosh S. Cisplatin: The first metal based anticancer drug. Bioorg Chem. 2019;88:102925
  2. Florea AM, Büsselberg D. Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers (Basel). 2011;3:1351-71
  3. Aldossary SA. Review on pharmacology of cisplatin: clinical use, toxicity and mechanism of resistance of cisplatin. Biomed Pharmacol J. 2019;12:7- 15
  4. Verma K, Sahu S, Saha S, Bahadur S, Bhardwaj SK. Review On Quercetin And Their Beneficial Properties. WJPPS. 2018;7:395-403
  5. Lakhanpal P, Rai DK. Quercetin: a versatile flavonoid. Internet Journal of Medical Update. 2007;2:22-37
  6. Ranawat P, Kaushik G, Saikia UN, Pathak CM, Khanduja KL. Quercetin impairs the reproductive potential of male mice. Andrologia. 2013;45:56-65
  7. Chang WS, Lee YJ, Lu FJ, Chiang HC. Inhibitory effects of flavonoids on xanthine oxidase. Anticancer Res. 1993;13:2165-70
  8. Calamia KT. Current and future use of anti-TNF agents in the treatment of autoimmune, inflammatory disorders. Adv Exp Med Biol. 2003;528:545-9
  9. Asadi M, Taghizadeh S, Kaviani E, Vakili O, Taheri-Anganeh M, Tahamtan M, et al. Caspase-3: Structure, function, and biotechnological aspects. Biotechnol Appl Biochem. 2021 Aug 3
  10. Kim PK, Mahidhara R, Seol DW. The role of caspase-8 in resistance to cancer chemotherapy. Drug Resist Updat. 2001;4:293-6
  11. Yang JN, Liu CX, Xu H, Pan QC. Caspases promoted DADAG-induced apoptosis in human leukemia HL-60 cells. Acta Pharmacol Sin. 2002;23:461-6
  12. Khalilzadeh B, Shadjou N, Kanberoglu GS, Afsharan H, De La Guardia M, Charoudeh HN, et al. Advances in nanomaterial based optical biosensing and bioimaging of apoptosis via caspase-3 activity: a review. Microchim Acta. 2018;185:1-9
  13. Katsuda H, Yamashita M, Katsura H, Yu J, Waki Y, Nagata N, et al. Protecting cisplatin-induced nephrotoxicity with cimetidine does not affect antitumor activity. Biol Pharm Bull. 2010;33:1867-71
  14. Cao X, Liu M, Tuo J, Shen D, Chan CC. The effects of quercetin in cultured human RPE cells under oxidative stress and in Ccl2/Cx3cr1 double deficient mice. Exp Eye Res. 2010;91:15-25
  15. Elbe H, Vardi N, Esrefoglu M, Ates B, Yologlu S, Taskapan C. Amelioration of streptozotocin-induced diabetic nephropathy by melatonin, quercetin, and resveratrol in rats. Hum Exp Toxicol. 2015;34:100-13
  16. Yao X, Panichpisal K, Kurtzman N, Nugent K. Cisplatin nephrotoxicity: a review. Am J Med Sci. 2007;334:115-24
  17. Suh SM, Tashjian AH Jr, Ma